Clinical Trials at NEXT Virginia

As of August 2026, 76 paid clinical trials are recruiting at NEXT Virginia, located at 12011 GOVERNMENT CENTER PKWY, SUITE 836, FAIRFAX, VA 22035-1100, phone (703) 324-7000 in Fairfax, Virginia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

View the full facility profile →

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

78 clinical trials at NEXT Virginia

·Clear filters·

Get a weekly email when new trials open in Fairfax, VA.

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

for Malignant Neoplasm

Sites in Fairfax +2 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07247110·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

for Colorectal Cancer

Sites in Fairfax +4 more locations

Sponsor: PAQ Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07300150·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

for Locally Advanced or Metastatic Malignant Solid Tumors

Sites in Fairfax +3 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07287995·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for Platinum-resistant Ovarian Cancer

Sites in Fairfax +6 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT07226427·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for Head and Neck Squamous Cell Carcinoma HNSCC

Sites in Fairfax +8 more locations

Sponsor: Sutro Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT07227168·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

for Advanced Solid Tumor

Sites in Fairfax +3 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07128303·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

for Advanced Solid Tumors

Sites in Fairfax +8 more locations

Sponsor: Accent Therapeutics

Sex: All·Age: 18+

Code: NCT06799065·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Sites in Fairfax +10 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07111520·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

for Participants With Advanced Solid Tumor Malignancies

Sites in Fairfax +4 more locations

Sponsor: VelaVigo Bio Inc

Sex: All·Age: 18+

Code: NCT07136779·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

for Advanced Solid Malignancies

Sites in Fairfax +3 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07223047·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

First In Human Study of CX-2051 in Advanced Solid Tumors

for Solid Tumor, Adult

Sites in Fairfax +7 more locations

Sponsor: CytomX Therapeutics

Sex: All·Age: 18+

Code: NCT06265688·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

for Solid Tumor

Drug: PT0253

Sites in Fairfax +6 more locations

Sponsor: PAQ Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06797336·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Fairfax +3 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06598800·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumor

Sites in Fairfax +10 more locations

Sponsor: Pliant Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06270706·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

for Metastatic Solid Tumors

Sites in Fairfax +7 more locations

Sponsor: Erasca, Inc.

Sex: All·Age: 18 - 99

Code: NCT06983743·Phase 1·Recruiting·Listed May 2025

Apply to this trial

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for Advanced Solid Tumors

Drug: Calderasib

Sites in Fairfax +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05067283·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

for Cancer

Sites in Fairfax +2 more locations

Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07317505·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

for Non-Small Cell Lung Cancer

Sites in Fairfax +5 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT05142189·Phase 1·Recruiting·Listed Dec 2021

Apply to this trial

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

for Solid Tumors

Sites in Fairfax +2 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07181681·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for Gynecologic Cancers

Sites in Fairfax +7 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT07024784·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

DPTX3186 in Wnt Pathway Activated Solid Tumors

for Solid Tumors

Sites in Fairfax +1 more location

Sponsor: Dewpoint Therapeutics

Sex: All·Age: 18+

Code: NCT07312903·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

for Non-Small Cell Lung Cancer

Sites in Fairfax +8 more locations

Sponsor: Pierre Fabre Medicament

Sex: All·Age: 18+

Code: NCT06043817·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Fairfax +7 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05954312·Phase 1·Recruiting·Listed Jul 2023

Apply to this trial

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

for Solid Tumours

Sites in Fairfax +7 more locations

Sponsor: Orion Corporation, Orion Pharma

Sex: All·Age: 18+

Code: NCT06725758·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study of HS-20110 in Participants With Advanced Solid Tumors

for Solid Tumors

Sites in Fairfax +6 more locations

Sponsor: Hansoh BioMedical R&D Company

Sex: All·Age: 18+

Code: NCT06892379·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Fairfax +3 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT06532565·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Fairfax +3 more locations

Sponsor: Peel Therapeutics Inc

Sex: All·Age: 18+

Code: NCT05329103·Phase 1·Recruiting·Listed Apr 2022

Apply to this trial

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

for Malignant Neoplasm

Sites in Fairfax +2 more locations

Sponsor: Tyligand Pharmaceuticals (Suzhou) Limited

Sex: All·Age: 18 - 75

Code: NCT06385925·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Fairfax +6 more locations

Sponsor: Tagworks Pharmaceuticals BV

Sex: All·Age: 18+

Code: NCT06959706·Phase 1·Recruiting·Listed May 2025

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Fairfax +6 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06804824·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

First in Human, Dose Escalation Study of AN4005

for Advanced Solid Tumor

Sites in Fairfax +3 more locations

Sponsor: Adlai Nortye Biopharma Co., Ltd.

Sex: All·Age: 18+

Code: NCT04999384·Phase 1·Recruiting·Listed Aug 2021

Apply to this trial

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

for Advanced Solid Tumors

Sites in Fairfax +5 more locations

Sponsor: Eikon Therapeutics

Sex: All·Age: 18 - 89

Code: NCT06907043·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for Cancer

Sites in Fairfax +3 more locations

Sponsor: OncoResponse, Inc.

Sex: All·Age: 18+

Code: NCT06090266·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for Solid Tumors

Sites in Fairfax +7 more locations

Sponsor: Adcentrx Therapeutics

Sex: All·Age: 18+

Code: NCT06710379·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

for KRAS-mutant Non-small Cell Lung Cancer (NSCLC)

Sites in Fairfax +8 more locations

Sponsor: Kestrel Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07458347·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for Non-small Cell Lung Cancer

Sites in Fairfax +19 more locations

Sponsor: Institut de Recherches Internationales Servier

Sex: All·Age: 18+

Code: NCT05786924·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial